Elsevier

Early Human Development

Volume 60, Issue 2, December 2000, Pages 149-155
Early Human Development

Serum soluble E- and L-selectin in the very early neonatal period

https://doi.org/10.1016/S0378-3782(00)00115-8Get rights and content

Abstract

Both E- and L-selectin are cell adhesion molecules. E-selectin is expressed by activated endothelial cells, whereas L-selectin by quiescent leukocytes and is rapidly cleaved off after activation. Both selectins take part in the first step of the ‘adhesion cascade’, the ‘rolling of leukocytes’, leading to the extravasation of the white cells to the sites of inflammation, infection or damage. For this reason their soluble forms (sE- and sL-selectin, respectively), are considered early and reliable markers of the immune activation and response. Moreover, sE-selectin has been reported to be a potent angiogenic factor and a reliable marker of infection and sepsis in neonates, as well as endothelial activation, while sL-selectin of the leukocyte function and maturity. Following informed maternal consent, we evaluated prospectively by ELISA, sE- and sL-selectin in the serum of 40 (19 females, 21 males), healthy, term, infection-free neonates, on the second and fifth day of life, and compared them with the respective values in 20 healthy adults (10 females, 10 males), with the purpose of examining the pattern of their values in the early postpartum days, and to establish reference values for both selectins. Values (mean±S.D.) of sE-selectin both on the second (139±48 ng/ml) and fifth day of life (111±35 ng/ml) were found to be highly increased, as compared with those in controls (48±13 ng/ml; P<4×10−11 and P<4×10−10, respectively), while sL-selectin values on both the second (674±223 ng/ml) and the fifth day of life (684±221 ng/ml), were significantly lower than those in controls (938±181 ng/ml); P<0.0001 and P<0.0003, respectively). A significant decrease was noted in sE-selectin values, from the second to the fifth day of life (P<10−7), while sL-selectin values showed no significant change in the same time interval. A strong correlation was found between values on the second and the fifth day of life of both sE- and sL-selectin (rP=0.885 and rP=0.813, respectively; P<0.00001). Neonatal values of both sE- and sL-selectin on the second or on the fifth day of life, did not depend on the perinatal factors, neonatal sex, or birth weight, mode of delivery, and maternal age or parity. In conclusion, in the very early neonatal period, our findings of highly increased sE-selectin, while low sL-selectin, suggest an immune and more specifically endothelial activation and an immature and decreased leukocyte function.

Introduction

Both E- and L-selectin are cell adhesion molecules. E-Selectin is expressed by the endothelium after activation at sites of acute inflammation and is significant in neutrophil and some T-cell migration to the site of injury [1], [2], [3]. L-Selectin is a 90–100-kDa surface glycoprotein, constitutively expressed by mammalian leukocytes, granulocytes, lymphocytes and monocytes. It is responsible for the initial leukocyte attachment to inflamed endothelium and high endothelial venules of peripheral lymph nodes [1], [4], [5]. After cellular activation, the extracellular part of L-selectin molecule is rapidly shed from the cell surface [1], [4], [5]. L-Selectin is down regulated by chemotactic agents and it is involved in homotypic aggregation [1]. Selectins are unique, because their role is restricted to direct leukocyte interaction with vascular endothelium and their ligands are carbohydrate epitopes on endothelial cells or on leukocytes [1]. Both selectins take part in the first step of the ‘adhesion cascade’, the ‘rolling of leukocytes’, leading to the extravasation of the white cells to the sites of inflammation, infection or damage [6]. For this reason, their soluble forms (sE- and sL-selectin, respectively), are considered early and reliable markers of the immune activation and response. Moreover, sE-selectin has been reported to be a potent angiogenic factor [7] and a reliable marker of infection and sepsis in neonates [8] as well as of endothelial activation [1], [6], while baseline sL-selectin of the leukocyte function and maturity [1].

The purpose of this study was to evaluate neonatal serum concentrations of the sE- and sL-selectin in the very early neonatal period, to establish reference values for both of them and to compare them with the respective ones in healthy adults.

Section snippets

Materials and methods

Following approval by the Ethics Committee of our Teaching Hospital and receipt of informed maternal consent, peripheral blood samples (∼1 ml) were obtained from 40 (21 males and 19 females) healthy, term neonates, of mean (range) gestational age at birth 39.5 weeks (37.0–42.0), birth weight 3250 g (2610–3860), on the second and fifth day of life. The neonates were infection-free as judged by clinical examination and serum CRP values (<3.5 mg/l), measured in the same samples as sE- and

Results

Mean (±S.D., min, max) values of sE- and sL-Selectin in box-plots, in the study population are depicted in Fig. 1, Fig. 2, respectively.

  • Neonatal serum values (mean±S.D.) of sE-Selectin both on the second (139±48 ng/ml) and fifth (111±35 ng/ml) day of life were found to be highly increased, as compared with those in controls (48±13 ng/ml; P<4×10−11 and P<4×10−10, respectively) (Fig. 1).

  • In contrast, sL-selectin values were significantly lower on both the second (674±223 ng/ml) and the fifth

Discussion

Our findings show that in healthy, term, infection-free neonates, both sE- and sL-selectin are essential constituents of the neonatal circulation from birth, suggesting that constitutive shedding of both selectins is an established component of the neonatal immune system, in agreement with previous reports on them [8], [9] and on adhesion molecules of the immunoglobulin superfamily [8], [10], [11].

The highly elevated neonatal serum sE-selectin values, more than double already from the second

References (25)

  • M. Berg et al.

    Human neutrophils release the Leu-8 lymphnode homing receptor during cell activation

    Blood

    (1990)
  • D.C. Anderson et al.

    Impaired transendothelial migration by neonatal neutrophils; abnormalities of Mac-1 (CD11b/CD18) dependent adherence reactions

    Blood

    (1990)
  • M.P. Bevilacqua

    Endothelial-leucocyte adhesion molecules

    Annu Rev Immunol

    (1993)
  • M.P. Bevilacqua et al.

    Identification of an inducible endothelial-leucocyte adhesion molecule

    Proc Natl Acad Sci USA

    (1987)
  • N. Graber et al.

    T cells bind cytokine activated endothelium via novel inducible sialoglycoprotein endothelial leucocyte adhesion molecule

    J Immunol

    (1990)
  • T.K. Kishimoto et al.

    Identification of a human peripheral lymph node homing receptor; a rapidly down-regulated adhesion molecule

    Proc Natl Acad Sci USA

    (1990)
  • T.A. Springer

    Adhesion receptors of the immune system

    Nature

    (1990)
  • A.E. Koch et al.

    Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1

    Nature

    (1995)
  • R. Austgulen et al.

    Infections in neonates delivered at term are associated with increased serum levels of ICAM-1 and E-selectin

    Acta Paediatr

    (1997)
  • J.M. Koening et al.

    Diminished soluble and total cellular L-selectin in cord blood is associated with its impaired shedding from activated neutrophils

    Pediatr Res

    (1996)
  • G. Giannaki et al.

    A comparative study of serum soluble VCAM-1 and ICAM-1 levels in the early neonatal period

    Acta Paediatr

    (1999)
  • I. Phocas et al.

    Soluble intercellular adhesion molecule-1 in newborn infants

    Eur J Pediatr

    (1998)
  • Cited by (16)

    • Normal and Abnormal Neutrophil Physiology in the Newborn

      2017, Fetal and Neonatal Physiology, 2-Volume Set
    • Translational research and biomarkers in neonatal sepsis

      2015, Clinica Chimica Acta
      Citation Excerpt :

      Besides the membrane-bound form of this adhesion molecule, soluble ICAM-1 (sICAM-1) has been proposed as an early biomarker of neonatal sepsis [127]. Significantly lower neonatal sICAM-1 have been found on the first and second day of life in comparison with the higher serum concentrations on the fourth and fifth postnatal days [128]. Measurement of sICAM-1 in neonatal sepsis showed significantly increased serum concentrations in comparison with the control group [129], with optimal cutoff points in EOS and LOS of 228 ng/mL and 368 ng/mL, respectively.

    • The utility of serial plasma sE-selectin measurements in the prediction of retinopathy of prematurity in premature infants

      2014, Early Human Development
      Citation Excerpt :

      It was also postulated by the same study that E-selectin played a pivotal role in mobilization and homing of circulating endothelial progenitor cells to the areas with reduced oxygen supply thereby enhancing neovascularization [19]. Angiogenesis and vascular growth are essential features of the perinatal period since there is an ongoing development and growth of the fetus and the newborn [29]. Therefore, it is not unusual to detect sE-selectin in the sera of term, as well as preterm neonates.

    • Integrins and Cell Adhesion Molecules

      2011, Fetal and Neonatal Physiology E-Book, Fourth Edition
    • Integrins and Cell Adhesion Molecules

      2003, Fetal and Neonatal Physiology: Third Edition
    View all citing articles on Scopus
    View full text